Taoyuan Lu

1.5k total citations · 1 hit paper
25 papers, 812 citations indexed

About

Taoyuan Lu is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Neurology. According to data from OpenAlex, Taoyuan Lu has authored 25 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 8 papers in Cancer Research and 7 papers in Neurology. Recurrent topics in Taoyuan Lu's work include Ferroptosis and cancer prognosis (6 papers), Intracranial Aneurysms: Treatment and Complications (6 papers) and Cerebrovascular and Carotid Artery Diseases (6 papers). Taoyuan Lu is often cited by papers focused on Ferroptosis and cancer prognosis (6 papers), Intracranial Aneurysms: Treatment and Complications (6 papers) and Cerebrovascular and Carotid Artery Diseases (6 papers). Taoyuan Lu collaborates with scholars based in China, United States and Germany. Taoyuan Lu's co-authors include Long Liu, Xinwei Han, Zaoqu Liu, Libo Wang, Chunguang Guo, Qin Dang, Siyuan Weng, Hui Xu, Yuyuan Zhang and Zhenqiang Sun and has published in prestigious journals such as Nature Communications, Frontiers in Immunology and Colloids and Surfaces A Physicochemical and Engineering Aspects.

In The Last Decade

Taoyuan Lu

23 papers receiving 807 citations

Hit Papers

Machine learning-based integration develops an immune-der... 2022 2026 2023 2024 2022 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Taoyuan Lu China 12 423 369 332 261 122 25 812
Yuchen Han China 16 424 1.0× 312 0.8× 184 0.6× 368 1.4× 67 0.5× 82 899
Niklas Klümper Germany 16 235 0.6× 443 1.2× 230 0.7× 280 1.1× 96 0.8× 74 793
Yushun Gao China 17 445 1.1× 481 1.3× 382 1.2× 248 1.0× 57 0.5× 84 1.1k
Naoyuki Okabe Japan 15 255 0.6× 212 0.6× 197 0.6× 392 1.5× 173 1.4× 56 706
Gengtai Ye China 13 344 0.8× 549 1.5× 373 1.1× 361 1.4× 178 1.5× 22 1.1k
Harald Hugenschmidt Norway 11 189 0.4× 384 1.0× 267 0.8× 417 1.6× 107 0.9× 13 826
Lianmin Zhang China 18 263 0.6× 304 0.8× 230 0.7× 452 1.7× 92 0.8× 40 820
J. Garcia United States 15 550 1.3× 378 1.0× 211 0.6× 328 1.3× 240 2.0× 41 934
Marissa S. Mattar United States 12 230 0.5× 290 0.8× 175 0.5× 313 1.2× 153 1.3× 22 666
Gilad W. Vainer Israel 14 213 0.5× 297 0.8× 245 0.7× 257 1.0× 78 0.6× 28 700

Countries citing papers authored by Taoyuan Lu

Since Specialization
Citations

This map shows the geographic impact of Taoyuan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taoyuan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taoyuan Lu more than expected).

Fields of papers citing papers by Taoyuan Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taoyuan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taoyuan Lu. The network helps show where Taoyuan Lu may publish in the future.

Co-authorship network of co-authors of Taoyuan Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Taoyuan Lu. A scholar is included among the top collaborators of Taoyuan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taoyuan Lu. Taoyuan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Tao, Jichang Luo, Eyad Almallouhi, et al.. (2024). Stenting versus medical treatment alone for symptomatic intracranial artery stenosis: a preplanned pooled individual patient data analysis. Journal of NeuroInterventional Surgery. 17(10). 1032–1039.
2.
Yang, Renjie, Jie Wang, Tao Wang, et al.. (2024). Anatomical predispositions for silent cerebral infarction postcarotid artery stenting: a retrospective cohort. International Journal of Surgery. 110(12). 7889–7899. 1 indexed citations
3.
He, Yanyan, Jia Liang, Chi Ma, et al.. (2024). Preparation of biocompatibility coating on magnesium alloy surface by sodium alginate and carboxymethyl chitosan hydrogel. iScience. 27(3). 109197–109197. 7 indexed citations
4.
Luo, Jichang, Xuesong Bai, Eyad Almallouhi, et al.. (2024). Stenting for symptomatic intracranial arterial stenosis with different qualifying arteries: a preplanned pooled individual patient data analysis. Stroke and Vascular Neurology. 10(4). 422–430. 1 indexed citations
5.
6.
Lu, Taoyuan, Yanyan He, Zaoqu Liu, et al.. (2023). A machine learning-derived gene signature for assessing rupture risk and circulatory immunopathologic landscape in patients with intracranial aneurysms. Frontiers in Cardiovascular Medicine. 10. 1075584–1075584. 2 indexed citations
7.
He, Yingkun, et al.. (2023). Vascular stability of brain arteriovenous malformations after partial embolization. CNS Neuroscience & Therapeutics. 30(3). e14136–e14136. 1 indexed citations
8.
He, Yanyan, et al.. (2022). Investigation of surface endothelialization on nitinol: Effects of composite hydrogel coatings. Colloids and Surfaces A Physicochemical and Engineering Aspects. 648. 129074–129074. 3 indexed citations
10.
Liu, Zaoqu, Long Liu, Siyuan Weng, et al.. (2022). Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer. Nature Communications. 13(1). 816–816. 455 indexed citations breakdown →
11.
Xing, Zhe, Zaoqu Liu, Xudong Fu, et al.. (2022). Clinical Significance and Immune Landscape of a Pyroptosis-Derived LncRNA Signature for Glioblastoma. Frontiers in Cell and Developmental Biology. 10. 805291–805291. 12 indexed citations
12.
Liu, Yiying, Taoyuan Lu, Zaoqu Liu, et al.. (2022). Six macrophage-associated genes in synovium constitute a novel diagnostic signature for osteoarthritis. Frontiers in Immunology. 13. 936606–936606. 32 indexed citations
13.
Guo, Chunguang, Zaoqu Liu, Can Cao, et al.. (2022). Development and Validation of Ischemic Events Related Signature After Carotid Endarterectomy. Frontiers in Cell and Developmental Biology. 10. 794608–794608. 5 indexed citations
14.
Guo, Chunguang, Zaoqu Liu, Yu Yin, et al.. (2022). Integrated Analysis of Multi-Omics Alteration, Immune Profile, and Pharmacological Landscape of Pyroptosis-Derived lncRNA Pairs in Gastric Cancer. Frontiers in Cell and Developmental Biology. 10. 816153–816153. 16 indexed citations
15.
Liu, Zaoqu, Long Liu, Taoyuan Lu, et al.. (2021). Hypoxia Molecular Characterization in Hepatocellular Carcinoma Identifies One Risk Signature and Two Nomograms for Clinical Management. Journal of Oncology. 2021. 1–20. 27 indexed citations
16.
Liu, Zaoqu, Taoyuan Lu, Yanli Wang, et al.. (2021). Establishment and experimental validation of an immune miRNA signature for assessing prognosis and immune landscape of patients with colorectal cancer. Journal of Cellular and Molecular Medicine. 25(14). 6874–6886. 33 indexed citations
17.
Wu, Haigang, et al.. (2021). Integrated Transcriptome Analysis Reveals the Impact of Photodynamic Therapy on Cerebrovascular Endothelial Cells. Frontiers in Oncology. 11. 731414–731414. 7 indexed citations
18.
Liu, Zaoqu, Taoyuan Lu, Jing Li, et al.. (2021). Clinical Significance and Inflammatory Landscape of aNovel Recurrence-Associated Immune Signature in Stage II/III Colorectal Cancer. Frontiers in Immunology. 12. 702594–702594. 43 indexed citations
19.
Liu, Zaoqu, Taoyuan Lu, Jing Li, et al.. (2021). Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer. Cancer Cell International. 21(1). 359–359. 33 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026